Archive for July, 2009

Testosterone

Friday, July 31st, 2009

J Med Assoc Thai. 2009 Apr;92(4):573-87.

From prenatal life into senescence, testosterone is essential requirement for manhood.

Pradidarcheep W, Showpittapornchai U.

Prenatally, organisms have the bipotentiality to differentiate along either male or female lines, a process with different stages, each with a narrow window of time, during which testosterone plays a pivotal role in the case of male sexual differentiation. During puberty, the body directs the masculinization process with growth of the genitalia and prostate. Body contours become male, with an average height of 10-15 centimeters greater than that of females, a greater bone and muscle mass, a male hair pattern and a male-type fat distribution. These pubertal developments, largely reversible in case of severe androgen deficiency,  require adult levels of testosterone throughout life. A new area of interest is in exploring how far age-related body changes (loss of bone and muscle mass, a shift into a higher ratio of body fat/lean body mass) are part of an age-related decline of testicular testosterone production. Therefore, throughout life, testosterone is essential for a normal male life.

Hair Loss

Hair Loss Secondary to Mesotherapy

Friday, July 31st, 2009

J Am Acad Dermatol. 2009 Jul 2.

Alopecia secondary to mesotherapy.

Duque-Estrada B, Vincenzi C, Misciali C, Tosti A.

Instituto de Dermatologia Prof. Rubem David Azulay, Rio de Janeiro,, Italy.

Mesotherapy has recently become an advertised method for the treatment of different types of alopecia despite the lack of any data regarding its efficacy and possible side effects. The substances injected into the scalp include “cocktails” of natural plant extracts, homoeopathic agents, vitamins, vasodilators, and drugs that may stimulate hair growth, such as finasteride and minoxidil. We report two cases of patchy alopecia that developed after mesotherapy for the treatment of androgenetic alopecia. In the first patient, alopecia developed after injections of the heparinoid vasodilator mesoglycan; the 3-month follow-up examination revealed a small residual area of cicatricial alopecia. The second patient developed reversible alopecia after multiple scalp injections of homeopathic agents. These cases underline the possible risks of
mesotherapy as a therapeutic technique for hair loss.

<a href=”http://www.drproctor.com”>Hair Loss</A>